Brief: Cytodyn Inc Says Two Additional Coronavirus Patients Treated With Co's Investigational New Drug, Leronlimab
23/03/2020 11:15
March 23 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN INC - TWO ADDITIONAL CORONAVIRUS PATIENTS TREATED
WITH
CO'S INVESTIGATIONAL NEW DRUG, LERONLIMAB
* CYTODYN - TREATMENT WITH LERONLIMAB BEING ADMINISTERED
UNDER
EMERGENCY IND RECENTLY GRANTED BY FDA
Source text for Eikon: ID:nGNX7YRGbl
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer